Psoriasis
Conditions
Interventions
A survey will be conducted on 22 people
In each participant 3 x 3 cm sites will be marked on the left and right forearms by a duly trained institution professional. The application rate of the product will be 2 mg / cm2 and the product will
E02.547.800.500:
Sponsors
Ipclin Instituto de Pesquisa Clínica Integrada Ltda
TCI Laboratório Biotecnológico LTDA.
Eligibility
Age
18 Years to 59 Years
Inclusion criteria
Inclusion criteria: Male and female; Age: 18 to 59 years old; Phototype: I to IV; Whole skin of the area;
Exclusion criteria
Exclusion criteria: Participants who refuse to participate in the study; Skin marks in the experimental area that interfere in the evaluation of possible skin reactions; Active dermatoses (local and disseminated) that may interfere with the results of the study; Pregnant or lactating women; Historic of allergic reactions, irritation or intense feelings of discomfort to topical products: cosmetics and medicines; Volunteers with a history of allergy to the material used in the study; Background of atopy; Participants with a history of allergy to products in the tested category; Immunodeficiency sufferers; Kidney, heart or liver transplantation; Forecast of bathing in the sea, pool or sauna during the study; Use of the following medications for systemic topical use: immunosuppressants, antihistamines, non-hormonal anti-inflammatory drugs, and corticosteroids up to two weeks before selection; Any condition not mentioned above that, in the opinion of the investigator, could compromise the evaluation of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It’s hoped to determine if the product is effective to promote skin hydration and the safety of the product | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected | — |
Countries
Brazil
Contacts
Public ContactJoão Seixas
Outcome results
None listed